Encorafenib and Binimetinib: A New Treatment Option for <i>BRAF</i><sup>V600E</sup>-Mutant Non-Small-Cell Lung Cancer.

Stinchcombe, Thomas E

Encorafenib and Binimetinib: A New Treatment Option for BRAF^V600E-Mutant Non-Small-Cell Lung Cancer.

Stinchcombe, Thomas E.

Affiliation

Stinchcombe TE; Division of Medical Oncology, Duke Cancer Institute, Durham, NC.

J Clin Oncol ; 41(21): 3679-3681, 2023 07 20.

Article in En | MEDLINE | ID: mdl-37270690

Subject(s)

Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Lung Neoplasms; Humans; Carcinoma, Non-Small-Cell Lung/drug therapy; Carcinoma, Non-Small-Cell Lung/genetics; Proto-Oncogene Proteins B-raf/genetics; Lung Neoplasms/drug therapy; Lung Neoplasms/genetics; Mutation; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cetuximab/therapeutic use; Colorectal Neoplasms/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Affiliation country: New Caledonia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google